The Official Comment of AHRMM to the United States Department of Health and Human Services Food and Drug Administration (FDA) regarding Unique Device Identification for Medical Devices Docket No. FDA-2011-N-0090

By AHRMM

AHRMM comments to the FDA regarding an amendment to the UDI proposed rule to address the UDI implementation time frame required by the 2012 Food and Drug Administration Safety and Innovation Act (FDASIA).

Related Resources

Podcasts
UDI and Providers: What You Need to Do
Get the basics on what healthcare supply chain and manufacturers, together with clinical and IT departments, must do to implement the Unique Device
Podcasts
Value Analysis 201: Organizing Data to Analyze Product and Equipment Clinical Outcomes
A value analysis process to verify the achievement of the outcomes desired will result in making decisions based on the data, celebrating achieveme
Webcast
Webcast: Building Trust: 10 Commandments of a Trusting Relationship
The intersection of CQO is patient care, Deborah Rey presents ten commandments you should adopt if they're not already part of your values both…
e-Learning
Supply Chain: Owning the Intersection of Cost, Quality, and Outcomes
e-Learning
The Process of Operationalizing Contracts to Support CQO
On-Demand Educational Webinars
Ordering, Shipping, and Materials Management: A Process Improvement Partnership Case Study
Learn about a comprehensive assessment and process improvement exercise on the Total Cost of Ownership model by UPMC and Cook Medical. Specific areas…